Osimertinib with or without Chemotherapy in <i>EGFR</i>-Mutated Advanced NSCLC
AstraZeneca
David Planchard; Pasi A Jänne; Ying Cheng; James C-H Yang; Noriko Yanagitani; Sang-We Kim; Shunichi Sugawara; Yan Yu; Yun Fan; Sarayut L Geater; Konstantin Laktionov; Chee K Lee; Natalia Valdiviezo; Samreen Ahmed; Jean-Marc Maurel; Igor Andrasina; Jonathan Goldman; Dana Ghiorghiu; Yuri Rukazenkov; Alex Todd; Kunihiko Kobayashi; FLAURA2 Investigators